88334-76-3

Usage

Uses

Used in Chemical Synthesis:
N-(3-aminopropyl)methanesulfonamide is used as a reagent in various chemical reactions for its ability to act as a building block in the synthesis of other organic compounds.
Used in Coordination Complexes:
N-(3-aminopropyl)methanesulfonamide is used as a metal-binding ligand in certain coordination complexes, contributing to the formation and stability of these complexes.
Used in Pharmaceutical Research:
N-(3-aminopropyl)methanesulfonamide is used in pharmaceutical research for its potential therapeutic applications, particularly in the treatment of neurodegenerative diseases and cancer. Its diverse chemical properties and potential biological activities make it a valuable compound for the development of new drugs and therapies.

Upstream product

• 1204669-77-1 tert-butyl {3-[(methylsulfonyl)amino]propyl}carbamate 

Downstream Products

• 1190043-83-4 4-(cyclopropylmethoxy)-N-{8-methyl-3-[({3-[(methylsulfonyl)amino]propyl}amino)methyl]quinolin-7-yl}benzamide 

Relevant academic research and scientific papers

INHIBITION OF OLIG2 ACTIVITY

Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of Olig2. Also described herein are methods of using such Olig2 inhibitors, alone and in combination with other compounds, for treating cancer and other diseases. In particular the Olig2 inhibitors may be used to treat glioblastoma.

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.

1,2,5-OXADIAZOLES AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE

The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.

HETEROCYCLIC COMPOUND

The present invention provides to a compound having melanin-concentrating hormone receptor antagonistic action and low toxicity, and useful as a agent for the prophylaxis or treatment of obesity and the like. The present invention relates to a compound re

INHIBITORS OF DIPEPTIDYL PEPTIDASE IV

The invention relates to compounds of the formula (I) or pharmaceutically-acceptable salts thereof wherein Ar, R 1 , R2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 have any of the meanings defined in the description, which possess dipeptidyl peptidase IV (DPP-IV) inhibitory activity and accordingly have value in the treatment of disease states associated with DPP-IV activity, such as diabetes mellitus. Processes for the preparation of said compounds, intermediates in said processes, pharmaceutical compositions containing said compounds or salts, and the use of said compounds or salts are also described.